References
- Chabner A. B., Ryan P. D., Ares L., Carbonero R., Calabresi P. The Pharmacological Basis of Therapeutics. Mc-Graw Hill Medical Publishing Division, New York 2000; 1411–1414
- Di Pietrantonio A. M., Hsieh T., Wu J. M. Activation of caspase-3 in HL-60 cells exposed to hydrogen peroxide. Biochem. Biophys. Res. Commun. 1999; 255: 477–482, [CSA]
- Forssen E. A., Tokes Z. Use of anionic liposomes for the reduction of chronic doxorubicin induced cardiotoxicity. Proc. Natl. Acad. Sci. USA. 1981; 78: 1873–1877, [PUBMED], [INFOTRIEVE], [CSA]
- Forssen E. A. Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes. United States Patent 1990; 49: 46683, [CSA]
- Freifelder D. Physical Biochemistry Application to Biochemistry and Molecular Biology, D Freifelder. W. H. Freeman and Company. 1982; 494–503
- Fresta M., Puglisi G., Panico A. M., Di Marco S., Mazzone G. CDP-choline entrapment and release from multilamellar and revese phase evaporation liposomes. Drug Dev. Ind. Pharm. 1993; 19: 559–585, [CSA]
- Gallois L., Fiallo M., Laigle A., Priebe W., Suillerot A. G. The overall partitioning of anthracyclines of phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids. Eur. J. Biochem. 1996; 241: 879–887, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gewirtz D. A. A critical evaluation of the mechanisms of action proposed for the anti tumour effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 1999; 57: 727–741, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gulati M., Grover M., Singh S., Singh M. Lipophillic drug derivatives in liposomes. Int. J. Pharm. 1998; 165: 129–168, [CROSSREF], [CSA]
- Harigan P. R., Wog K. F., Redelmeier T. E., Wheeler J. J., Cullis P. R. Accumulation of doxorubicin and other lipophillic amines into large unilamellar vesicles in response to transmembrane pH gradients. Biochim. Biophys. Acta. 1993; 1149: 329–338, [CSA]
- Johnson T. M., Yu Z. X., Ferrana V. J., Lowenstein R. A., Finkel T. Reactive oxygen species are down stream mediators of p53 dependent apoptosis. Proc. Natl. Acad. Sci. USA. 1996; 93: 11848–11852, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Liotta L. A. Multidrug resistance in cancer. Medicine Special Issue 1992; 142–149, [CSA]
- Mamot C., Drummond D. C., Hong K., Kirpotin D. B., Park J. Liposome based approaches to overcome anticancer drug resistances. Drug Resistance Updates 2003a; 6: 271–279, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mamot C., Drummond D. C., Greiser U., Hong K. Epidermal growth factor recptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR and EGFRvIII-overexpressing tumor cells. Cancer Res 2003b; 63: 3154–3161, [PUBMED], [INFOTRIEVE], [CSA]
- Mayer L. D., Madden T. D., Bally M. B., Cullis P. R. Liposome Technology. CRC Press, Boca Raton, FL 1993; II: 27–44
- Olson R. D., Mushlin P. S. Doxorubicin cardiotoxicity: analysis of prevailing hypothesis. FASEB J 1990; 4: 3076–3086, [PUBMED], [INFOTRIEVE], [CSA]
- Pan X. Q., Zheng X., Shi G., Wang H., Ratnam M., Lee R. J. Strategy for the treatment of acute myelogenous leukemia based on folate receptor β-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid. Blood 2002; 100: 594–602, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pelicano H., Carney D., Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resistance Updates 2004; 6: 97–110, [CROSSREF], [CSA]
- Rahman A., Kessler A., Newton M., Branimir S., Geoffrey R., Paul W., Schein P. Liposomal protection of adriamycin induced cardiotoxicity in Mice. Cancer Res 1980; 40: 1532–1537, [PUBMED], [INFOTRIEVE], [CSA]
- Remers W. A. Textbook of Organic Medicinal and Pharmaceutical Chemistry, J. N. Delgado, W. A. Remers. Lippincott-Raven. 1998; 356–358
- Sawa T., Wu J., Akaike T., Maeda H. Tumor-targeting chemotherapy by a xanthine oxidase-polymer conjugate that generates oxygen-free radicals in tumor tissue. Cancer Res 2000; 60: 666–671, [PUBMED], [INFOTRIEVE], [CSA]
- Woodle M. C., Papahadjopoulos D. Liposome preparation and size characterization. Methods Enzymol 1989; 171: 193–217, [PUBMED], [INFOTRIEVE], [CSA]
- Yoshikawa T., Kokura S., Tainaka K., Naito Y., Kondo M. A novel cancer therapy based on oxygen radicals. Cancer Res 1995; 55: 1617–1620, [PUBMED], [INFOTRIEVE], [CSA]